An update on microRNAs as potential novel therapeutic targets in testicular germ cell tumors

被引:5
|
作者
De Martino, Marco [1 ,2 ]
Esposito, Francesco [2 ]
Chieffi, Paolo [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dipartimento Psicol, Caserta 31, I-81100 Caserta, Italy
[2] Univ Napoli Federico II, CNR, Ist Endocrinol Oncol Sperimentale, Dipartimento Med Mol & Biotecnol Med, Naples, Italy
关键词
HMGA1; microRNA; testicular germ cell tumor (TGCT); seminoma; RECEPTOR-BETA; EXPRESSION; BIOMARKERS; PROTEIN; DIAGNOSIS; BIOLOGY; CANCER; GPR30; A2;
D O I
10.5582/irdr.2020.03025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Testicular germ cell tumors (TGCTs) are the most frequent solid malignant tumors in men 2040 years of age and the most frequent cause of death from solid tumors in this age group. Recent studies have underscored the fact that miRNA deregulation is a feature of carcinogenesis, including TGCT development and progression. MiRNAs are a group of small noncoding RNAs that bind to the 3'-untranslated region (UTR) of the targeted mRNAs, thus causing mRNA degradation or the inhibition of its translation, regulating gene expression in a temporal and tissue-specific manner. However, few miRNAs have been found to play key roles in TGCTs; recently, other miRNAs have been identified, representing novel potential therapeutic targets.
引用
收藏
页码:184 / 186
页数:3
相关论文
共 50 条
  • [21] Identification of novel potential genes in testicular germ cell tumors: A transcriptome analysis
    Zheng, Shaokai
    Li, Ting
    Qiu, Lianglin
    CANCER BIOMARKERS, 2023, 38 (02) : 261 - 272
  • [22] Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
    Lengert, Andre van Helvoort
    Braga Pereira, Leticia do Nascimento
    Martins Cabral, Eduardo Ramos
    Faria Gomes, Izabela Natalia
    de Jesus, Lais Machado
    Santiago Goncalves, Maria Fernanda
    da Rocha, Aline Oliveira
    Tassinari, Tiago Alexandre
    da Silva, Luciane Sussuchi
    Laus, Ana Carolina
    Vidal, Daniel Onofre
    Pinto, Mariana Tomazini
    Reis, Rui Manuel
    Lopes, Luiz Fernando
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (08):
  • [23] High chromosome numbers of testicular germ cell tumors - An update
    Atkin, NB
    Baker, MC
    CANCER GENETICS AND CYTOGENETICS, 1995, 84 (01) : 90 - 90
  • [24] Emerging Therapeutic Targets for Male Germ Cell Tumors
    Fankhauser, Christian Daniel
    Honecker, Friedemann
    Beyer, Joerg
    Bode, Peter Karl
    CURRENT ONCOLOGY REPORTS, 2015, 17 (12)
  • [25] Emerging Therapeutic Targets for Male Germ Cell Tumors
    Christian Daniel Fankhauser
    Friedemann Honecker
    Jörg Beyer
    Peter Karl Bode
    Current Oncology Reports, 2015, 17
  • [26] EGFR and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors
    Budhipramono, Albert
    Rakheja, Dinesh
    Chen, Kenneth S.
    Fustino, Nicholas
    Shukla, Abhay
    Wickiser, Jonathan
    Laetsch, Theodore
    Amatruda, James F.
    CANCER RESEARCH, 2016, 76
  • [27] Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review)
    Zhan, Ziqing
    Luo, Xia
    Shi, Jiaxin
    Chen, Litao
    Ye, Meng
    Jin, Xiaofeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2025, 29 (04)
  • [28] GPR30: A new potential therapeutic target in human testicular germ cell tumors
    Chieffi, Paolo
    INTRACTABLE & RARE DISEASES RESEARCH, 2021, 10 (04) : 292 - 293
  • [29] TESTICULAR GERM-CELL TUMORS - AN UPDATE ON CLINICAL PATHOLOGICAL CORRELATION
    ABUJAWDEH, GM
    OYASU, R
    ACTA PATHOLOGICA JAPONICA, 1991, 41 (02): : 83 - 93
  • [30] The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors
    Lafin, John T.
    Murray, Matthew J.
    Coleman, Nicholas
    Frazier, A. Lindsay
    Amatruda, James F.
    Bagrodia, Aditya
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (03) : 269 - 271